2021
DOI: 10.1002/nbm.4623
|View full text |Cite
|
Sign up to set email alerts
|

Not only manganese, but fruit component effects dictate the efficiency of fruit juice as an oral magnetic resonance imaging contrast agent

Abstract: Proteins JOYNLABSeveral fruit juices are used as oral contrast agents to improve the quality of images in magnetic resonance cholangiopancreatography. They are often preferred to conventional synthetic contrast agents because of their very low cost, natural origin, intrinsic safety, and comparable image qualities. Pineapple and blueberry juices are the most employed in clinical practice due to their higher content of manganese(II) ions. The interest of pharmaceutical companies in these products is testified by… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
3

Relationship

1
2

Authors

Journals

citations
Cited by 3 publications
(1 citation statement)
references
References 31 publications
0
1
0
Order By: Relevance
“…The strategy to reduce the risks associated with the administration of contrast agents without reducing the quality, and thus the diagnostic accuracy, of the MRI images, passes through the use of molecules not containing gadolinium­(III) ions but similarly able to enhance the nuclear relaxation rates of water protons, or through the development of gadolinium complexes with higher efficiency so that the injected dose can be sizably reduced. A reduction of the injected gadolinium­(III) dose can be achieved (i) by targeting the contrast agents to specifically accumulate them in the tissues of interest and (ii) by increasing the capability of the agents to enhance the water proton relaxation rates.…”
Section: Introductionmentioning
confidence: 99%
“…The strategy to reduce the risks associated with the administration of contrast agents without reducing the quality, and thus the diagnostic accuracy, of the MRI images, passes through the use of molecules not containing gadolinium­(III) ions but similarly able to enhance the nuclear relaxation rates of water protons, or through the development of gadolinium complexes with higher efficiency so that the injected dose can be sizably reduced. A reduction of the injected gadolinium­(III) dose can be achieved (i) by targeting the contrast agents to specifically accumulate them in the tissues of interest and (ii) by increasing the capability of the agents to enhance the water proton relaxation rates.…”
Section: Introductionmentioning
confidence: 99%